# ETS1

## Overview
ETS1 is a gene that encodes the ETS proto-oncogene 1, transcription factor, a pivotal protein involved in various cellular functions including gene expression regulation, development, and cellular differentiation. The ETS1 protein is a member of the ETS family of transcription factors, characterized by an ETS domain responsible for specific DNA-binding and a range of protein-protein interactions. This transcription factor is not only crucial in normal cellular processes but also plays significant roles in pathological conditions such as cancer and autoimmune diseases. The protein's activity is modulated by several mechanisms including phosphorylation and interaction with other transcription factors, which can enhance or inhibit its function depending on the cellular context (Garrett-Sinha2013Review; dittmer2003biology).

## Structure
The ETS1 protein, encoded by the ETS1 gene, is characterized by a complex molecular structure that includes several distinct domains crucial for its function as a transcription factor. The primary structure of ETS1 features a winged helix-turn-helix motif within the ETS domain, spanning amino acids 331 to 415, which is essential for DNA-binding activity. This domain binds to the core DNA sequence 5'-GGA(A/T)-3' and is involved in recognizing specific DNA sequences to regulate gene expression (Seidel2002An; dittmer2003biology).

Secondary structure elements include alpha helices and beta strands that form the ETS domain, with helix H3 interacting with the major groove of DNA and a winged loop contacting the minor groove (dittmer2003biology). The Pointed (PNT) domain, located between amino acids 54 and 135, consists of five alpha helices and does not resemble typical protein or DNA-binding interfaces (dittmer2003biology).

ETS1 also exhibits an autoinhibitory module composed of alpha helices (HI-1, HI-2, and H4) that interact with each other and with helix H1 of the ETS domain to regulate DNA binding. This interaction forms a metastable inhibitory module, crucial for the autoinhibition of Ets-1 (Cowley2000Phosphorylation).

Post-translational modifications of ETS1 include phosphorylation, which plays a significant role in regulating its DNA-binding activity. Specifically, phosphorylation at threonine-38 enhances its transcriptional activity, while calcium-dependent phosphorylation near the amino-terminal inhibitory helices reinforces the autoinhibitory mechanism (Fisher1994Realâtime; Cowley2000Phosphorylation).

Additionally, ETS1 exists in multiple splice variant isoforms, including p54 c-ets1 (full length) and p42 c-ets1 (ÎVII-Ets1), which differ based on the inclusion or exclusion of specific exons, affecting the protein's regulatory functions and interactions with other proteins (Fisher1994Realâtime).

## Function
ETS1, encoded by the ETS1 gene, is a transcription factor that plays a pivotal role in various cellular processes in healthy human cells. It is involved in transcriptional regulation, where it modulates DNA binding affinity, often in cooperation with other transcription factors such as AML-1, Pit-1, and HIF-2Î±. These interactions can either enhance or inhibit ETS1's DNA binding activity, which is crucial for the regulation of gene expression related to cell growth, development, and differentiation (dittmer2003biology).

ETS1 is also essential for the immune system, particularly in the development and function of T cells and B cells. It regulates key genes during T-cell activation and collaborates with Pax5 in B-cell maturation. Its expression is notably high in lymphoid tissues such as the thymus, spleen, and lymph nodes (Garrett-Sinha2013Review; dittmer2003biology).

Furthermore, ETS1 is involved in angiogenesis, stimulating the production of proteases and regulating the expression of vascular endothelial growth factor (VEGF) and its receptors, which are essential for blood vessel formation (dittmer2003biology). This transcription factor also plays a role in apoptosis, exhibiting both pro-apoptotic and anti-apoptotic effects depending on the cell type, thus influencing cell survival and proliferation (dittmer2003biology).

Overall, ETS1's function in transcription regulation, immune response, angiogenesis, and apoptosis underscores its importance in maintaining cellular and organismal homeostasis.

## Clinical Significance
ETS1, a gene encoding a transcription factor, is implicated in various human diseases, primarily through its role in cancer progression and immune system disorders. In cancer, ETS1 is often overexpressed, contributing to increased tumorigenicity, invasiveness, metastasis, and resistance to therapy. This overexpression is particularly noted in cancers such as breast, prostate, and acute monocytic leukemia, where it is associated with poor prognosis and advanced disease stages (A2018Aberrant; Dittmer2015The; Findlay2013Understanding). ETS1 also plays a role in hematopoietic tumors, where it functions as an oncogene, often upregulated in human tumors like B cell lymphomas and acute myeloid leukemia (Garrett-Sinha2013Review).

In the context of autoimmune diseases, ETS1 is linked to systemic lupus erythematosus (SLE). Genetic variants of ETS1 have been identified in genome-wide association studies as contributing to this autoimmune disorder. Ets1 knockout mice exhibit lupus-like disease characteristics, suggesting its critical role in immune regulation (Findlay2013Understanding).

Furthermore, ETS1 is involved in cardiovascular conditions, mediating vascular inflammation and remodeling in response to stimuli like angiotensin II, which underscores its role in vascular injury responses (Findlay2013Understanding). These findings highlight the clinical significance of ETS1 in a range of pathological conditions, making it a potential target for therapeutic interventions.

## Interactions
ETS1, a transcription factor encoded by the ETS1 gene, engages in various physical interactions with both nucleic acids and other proteins, playing a crucial role in gene regulation. ETS1 binds to DNA at specific Ets-binding sites (EBSs), recognizing sequences primarily through the H3 helix which inserts into the major groove of DNA. This interaction is critical for the transcriptional regulation of target genes (Cooper2014Recent).

ETS1 also forms homodimeric complexes, enhancing its DNA-binding capability through cooperative binding to repeated DNA elements at palindromic sites. This dimerization involves head-to-head arrangements and domain-swapped interactions between ETS1 units, which are stabilized by reciprocal hydrogen bonds and van der Waals interactions (Lamber2008Regulation; Cooper2014Recent).

Furthermore, ETS1 interacts with other transcription factors such as Runx1, Runx2, and Pax5. These interactions modulate ETS1's activity and extend its functional versatility in tissue-specific transcriptional regulation (Babayeva2010Structural). Notably, the interaction with Runx1 involves the Ets1 interacting domain (EID) of Runx1, which engages with ETS1 through hydrophobic and hydrogen bonding, enhancing ETS1's DNA-binding activity by displacing its inhibitory module (Shrivastava2014Structural).

Additionally, ETS1 interacts with DNA repair enzymes like DNA-PK and PARP-1, which post-translationally modify ETS1, affecting its transcriptional activity. These interactions involve significant interfaces including the ETS domain's Î±-helix H1, highlighting the role of ETS1 in cellular response to DNA damage (de2018Computational).


## References


[1. (Babayeva2010Structural) Nigar D. Babayeva, Phillip J. Wilder, Masaaki Shiina, Koshiki Mino, Michelle Desler, Kazuhiro Ogata, Angie Rizzino, and Tahir H. Tahirov. Structural basis of ets1 cooperative binding to palindromic sequences on stromelysin-1 promoter dna. Cell Cycle, 9(15):3126â3134, August 2010. URL: http://dx.doi.org/10.4161/cc.9.14.12257, doi:10.4161/cc.9.14.12257. (42 citations) 10.4161/cc.9.14.12257](https://doi.org/10.4161/cc.9.14.12257)

[2. (Lamber2008Regulation) Ekaterina P Lamber, Laurent Vanhille, Larissa C Textor, Galina S Kachalova, Michael H Sieweke, and Matthias Wilmanns. Regulation of the transcription factor ets-1 by dna-mediated homo-dimerization. The EMBO Journal, 27(14):2006â2017, June 2008. URL: http://dx.doi.org/10.1038/emboj.2008.117, doi:10.1038/emboj.2008.117. (51 citations) 10.1038/emboj.2008.117](https://doi.org/10.1038/emboj.2008.117)

[3. (Garrett-Sinha2013Review) Lee Ann Garrett-Sinha. Review of ets1 structure, function, and roles in immunity. Cellular and Molecular Life Sciences, 70(18):3375â3390, January 2013. URL: http://dx.doi.org/10.1007/s00018-012-1243-7, doi:10.1007/s00018-012-1243-7. (197 citations) 10.1007/s00018-012-1243-7](https://doi.org/10.1007/s00018-012-1243-7)

[4. (Dittmer2015The) JÃ¼rgen Dittmer. The role of the transcription factor ets1 in carcinoma. Seminars in Cancer Biology, 35:20â38, December 2015. URL: http://dx.doi.org/10.1016/j.semcancer.2015.09.010, doi:10.1016/j.semcancer.2015.09.010. (186 citations) 10.1016/j.semcancer.2015.09.010](https://doi.org/10.1016/j.semcancer.2015.09.010)

[5. (Cooper2014Recent) Christopher D.O. Cooper, Joseph A. Newman, and Opher Gileadi. Recent advances in the structural molecular biology of ets transcription factors: interactions, interfaces and inhibition. Biochemical Society Transactions, 42(1):130â138, January 2014. URL: http://dx.doi.org/10.1042/bst20130227, doi:10.1042/bst20130227. (32 citations) 10.1042/bst20130227](https://doi.org/10.1042/bst20130227)

[6. (A2018Aberrant) Elizabeth A Fry and Kazushi Inoue. Aberrant expression of ets1 and ets2 proteins in cancer. Cancer Reports and Reviews, 2018. URL: http://dx.doi.org/10.15761/crr.1000151, doi:10.15761/crr.1000151. (45 citations) 10.15761/crr.1000151](https://doi.org/10.15761/crr.1000151)

[7. (Fisher1994Realâtime) Robert J. Fisher, Matthew Fivash, Jose CasasâFinet, John W. Erickson, Akiko Kondoh, Sharon V. Bladen, Constance Fisher, Dennis K. Watson, and Takis Papas. Realâtime dna binding measurements of the etsl recombinant oncoproteins reveal significant kinetic differences between the p42 and p51 isoforms. Protein Science, 3(2):257â266, February 1994. URL: http://dx.doi.org/10.1002/pro.5560030210, doi:10.1002/pro.5560030210. (103 citations) 10.1002/pro.5560030210](https://doi.org/10.1002/pro.5560030210)

[8. (Shrivastava2014Structural) T Shrivastava, K Mino, N D Babayeva, O I Baranovskaya, A Rizzino, and T H Tahirov. Structural basis of ets1 activation by runx1. Leukemia, 28(10):2040â2048, March 2014. URL: http://dx.doi.org/10.1038/leu.2014.111, doi:10.1038/leu.2014.111. (48 citations) 10.1038/leu.2014.111](https://doi.org/10.1038/leu.2014.111)

[9. (de2018Computational) Jerome de Ruyck, Guillaume Brysbaert, Vincent Villeret, Marc Aumercier, and Marc F. Lensink. Computational characterization of the binding mode between oncoprotein etsâ1 and dnaârepair enzymes. Proteins: Structure, Function, and Bioinformatics, 86(10):1055â1063, September 2018. URL: http://dx.doi.org/10.1002/prot.25578, doi:10.1002/prot.25578. (3 citations) 10.1002/prot.25578](https://doi.org/10.1002/prot.25578)

[10. (dittmer2003biology) Dittmer, JÃ¼rgen. "The biology of the Ets1 proto-oncogene." Molecular cancer 2 (2003): 1-21. (538 citations) 10.1186/1476-4598-2-29](https://doi.org/10.1186/1476-4598-2-29)

[11. (Cowley2000Phosphorylation) Dale O. Cowley and Barbara J. Graves. Phosphorylation represses ets-1 dna binding by reinforcing autoinhibition. Genes &amp; Development, 14(3):366â376, February 2000. URL: http://dx.doi.org/10.1101/gad.14.3.366, doi:10.1101/gad.14.3.366. (112 citations) 10.1101/gad.14.3.366](https://doi.org/10.1101/gad.14.3.366)

[12. (Findlay2013Understanding) Victoria J. Findlay, Amanda C. LaRue, David P. Turner, Patricia M. Watson, and Dennis K. Watson. Understanding the Role of ETS-Mediated Gene Regulation in Complex Biological Processes, pages 1â61. Elsevier, 2013. URL: http://dx.doi.org/10.1016/b978-0-12-407190-2.00001-0, doi:10.1016/b978-0-12-407190-2.00001-0. (115 citations) 10.1016/b978-0-12-407190-2.00001-0](https://doi.org/10.1016/b978-0-12-407190-2.00001-0)

[13. (Seidel2002An) Jeffrey J. Seidel and Barbara J. Graves. An erk2 docking site in the pointed domain distinguishes a subset of ets transcription factors. Genes &amp; Development, 16(1):127â137, January 2002. URL: http://dx.doi.org/10.1101/gad.950902, doi:10.1101/gad.950902. (142 citations) 10.1101/gad.950902](https://doi.org/10.1101/gad.950902)